Witnessing the stock’s movement on the chart, on Thursday, Alto Neuroscience Inc (NYSE: ANRO) had a quiet start as it plunged -4.22% to $4.09, before settling in for the price of $4.27 at the close. Taking a more long-term approach, ANRO posted a 52-week range of $3.61-$24.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -50.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 73.48%. This publicly-traded company’s shares outstanding now amounts to $26.88 million, simultaneously with a float of $21.98 million. The organization now has a market capitalization sitting at $110.31 million. At the time of writing, stock’s 50-day Moving Average stood at $8.96, while the 200-day Moving Average is $12.13.
Alto Neuroscience Inc (ANRO) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Alto Neuroscience Inc’s current insider ownership accounts for 18.48%, in contrast to 83.60% institutional ownership. According to the most recent insider trade that took place on Jul 09 ’24, this organization’s CHIEF MEDICAL OFFICER bought 12,069 shares at the rate of 12.60, making the entire transaction reach 152,085 in total value, affecting insider ownership by 36,920. Preceding that transaction, on Jul 10 ’24, Company’s CHIEF MEDICAL OFFICER bought 2,931 for 13.22, making the whole transaction’s value amount to 38,748. This particular insider is now the holder of 39,851 in total.
Alto Neuroscience Inc (ANRO) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Alto Neuroscience Inc’s EPS increase for this current 12-month fiscal period is 73.48% and is forecasted to reach -2.49 in the upcoming year.
Alto Neuroscience Inc (NYSE: ANRO) Trading Performance Indicators
Let’s observe the current performance indicators for Alto Neuroscience Inc (ANRO). It’s Quick Ratio in the last reported quarter now stands at 13.09. The Stock has managed to achieve an average true range (ATR) of 0.62.
In the same vein, ANRO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.13, a figure that is expected to reach -0.64 in the next quarter, and analysts are predicting that it will be -2.49 at the market close of one year from today.
Technical Analysis of Alto Neuroscience Inc (ANRO)
Going through the that latest performance of [Alto Neuroscience Inc, ANRO]. Its last 5-days volume of 0.39 million indicated improvement to the volume of 0.38 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 40.08% While, its Average True Range was 0.51.
Raw Stochastic average of Alto Neuroscience Inc (ANRO) in the period of the previous 100 days is set at 3.44%, which indicates a major fall in contrast to 35.04% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 90.66% that was lower than 209.36% volatility it exhibited in the past 100-days period.
